Viewing StudyNCT00461708



Ignite Creation Date: 2024-05-05 @ 5:29 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00461708
Status: COMPLETED
Last Update Posted: 2015-10-15
First Post: 2007-04-17

Brief Title: A Study of Tarceva Erlotinib in Combination With Gemcitabine in Unresectable andor Metastatic Cancer of the Pancreas Relationship Between Skin Toxicity and Survival
Sponsor:
Organization: Hoffmann-La Roche

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 153
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: